Skip to content

Oral feeding versus nasogastric feeding in predicted severe acute pancreatitis: a randomized controlled trial

Oral feeding versus nasogastric feeding in predicted severe acute pancreatitis: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15005921
Enrollment
Unknown
Registered
2015-02-02
Start date
2015-01-22
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pancreatitis

Interventions

oral feeding group (OF):conventional medical management
oral feeding group (OF):oral feeding
NG feeding group (NGF):conventional medical management
NG feeding group (NGF):insertion of NG tube and decompression
NG feeding group (NGF):NG feeding

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with acute pancreatitis: showing 2 of the following three features: (1)acute upper abdominal pain; (2)serum amylase or lipase increased 3 times more than normal maximum level; (3)with characteristics of acute pancreatitis on computed tomography, MRI or transabdominal ultrasonography; 2. Admission within 48h from the onset of symptoms; 3. Age: >18 years old; 4. Showing 1 of the followings: (1)APACHE II score=8; (2)massive peripancreatic fluid collection on CT scan; 5. Patients voluntarily signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Gastric retention presenting from clinical symptom, physical signs or abdominal CT examination; 2. Women in pregnancy or lactation; 3. Patients with severe diseases of heart, lung, brain or kidney; 4. Patients with other severe digestive diseases, such as cirrhosis, esophageal varices, peptic ulcer, ulcerative colitis, Crohn’s disease, malignant tumors; 5. Patients with drug abuse, psychinosis.

Design outcomes

Primary

MeasureTime frame
incidence of infection;mortality;

Secondary

MeasureTime frame
APACHE II score;numeric rating score of abdominal pain;numeric rating score of throat discomfort;MOF score;SIRS score;modified CT severity index;length of stay;cost of hospitalization;

Countries

China

Contacts

Public ContactLibin Huang
huanglibin525@163.com+86 18980601869

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026